Loading…
Loading…
Bio-Techne Corp
NASDAQ · Stock Profile · Market Cap $7.92B
Current Price
$50.81
-0.49%GoodMoat Value
$3.90
92.3% overvaluedPrice sits at 18% of its 52-week range.
Forward estimates use -17.1% FCF growth (CAGR)
Net Debt: 178M
1.2B
FY24
289M
FY24
297M
FY24
316M
FY25
1.2B
FY25
287M
FY25
296M
FY25
168M
FY24
34M
FY24
35M
FY24
23M
FY25
73M
FY25
38M
FY25
38M
FY25
Contact: David Clair, Senior Director, Corporate Development [email protected] 612-656-4416 SOURCE Bio-Techne Corporation Related Links https://www.bio-techne.com/
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
Minnesota, USA
Price sits at 18% of its 52-week range.
Blended fair value estimate based on DCF, Graham Number, and earnings-based models.
Run a full DCF analysis with customizable assumptions
Open DCF Calculator →Graham Number, PEG-based, and Earnings-based models
View Fair Value →Dividend Yield
0.16%
Contact: David Clair, Senior Director, Corporate Development [email protected] 612-656-4416 SOURCE Bio-Techne Corporation Related Links https://www.bio-techne.com/
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
Minnesota, USA